Hydroxychloroquine sulfate Description: Difference between revisions
No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Hydroxychloroquine sulfate}} | |||
{{CMG}}; {{AE}} {{chetan}} | |||
==Description== | ==Description== | ||
| Line 12: | Line 16: | ||
Molecular Weight of 433.95 | Molecular Weight of 433.95 | ||
Each tablet, for oral administration, contains 200 mg hydroxychloroquine sulfate, USP (equivalent to 155 mg base). In addition, each tablet contains the following Inactive Ingredients: colloidal silicon dioxide, dibasic calcium phosphate, hypromellose, macrogol/PEG 3350, magnesium stearate, polysorbate 80, pregelatinized starch, talc, and titanium dioxide. | Each tablet, for oral administration, contains 200 mg hydroxychloroquine sulfate, USP (equivalent to 155 mg base). In addition, each tablet contains the following Inactive Ingredients: colloidal silicon dioxide, dibasic calcium phosphate, hypromellose, macrogol/PEG 3350, magnesium stearate, polysorbate 80, pregelatinized starch, talc, and titanium dioxide.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE) TABLET, FILM COATED [IPCA LABORATORIES LIMITED] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22d4d993-b86d-478e-ac6d-7bcd217e9906 | publisher = | date = | accessdate = }}</ref> | ||
==References== | |||
{{Reflist}} | |||
{{FDA}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Latest revision as of 23:51, 7 January 2014
| Hydroxychloroquine sulfate |
|---|
| HYDROXYCHLOROQUINE SULFATE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications And Usage |
| Contraindications |
| Warnings And Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage And Administration |
| How Supplied |
| Labels And Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Description
Hydroxychloroquine sulfate, USP is a colorless crystalline solid, soluble in water to at least 20 percent; chemically the drug is 2-[[4-[(7-Chloro-4-quinolyl) amino]pentyl] ethylamino] ethanol sulfate (1:1). Hydroxychloroquine sulfate, USP has the following structural formula:
 |
Molecular Weight of 433.95
Each tablet, for oral administration, contains 200 mg hydroxychloroquine sulfate, USP (equivalent to 155 mg base). In addition, each tablet contains the following Inactive Ingredients: colloidal silicon dioxide, dibasic calcium phosphate, hypromellose, macrogol/PEG 3350, magnesium stearate, polysorbate 80, pregelatinized starch, talc, and titanium dioxide.[1]
References
Adapted from the FDA Package Insert.